Newsroom

Actavis builder aims to pump up Alvogen

Posted on 29.7.2009 in: People

Remember Robert Wessman? The Icelandic businessman, who stepped down as CEO of Actavis about a year ago, is plotting a new assault on the generics business, using the U.S.-based Alvogen Group as a platform.
Fierce Pharma